Key facts
- J2 Health’s last known valuation is $19.4M (Mar 2022).
- It has raised $5.4M across 1 recorded rounds; the latest was Seed Round ($1.0M) in Mar 2025.
- Notable investors include BoxGroup, Tiger Global Management, Greycroft, Primary Venture Partners, Mario Schlosser.
- J2 Health has filed 1 Form D with the SEC, most recently Apr 2025 ($1.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for J2 Health
Funding rounds
1 roundsAbout J2 Health
Developer of provider-network adequacy and network analytics software designed for healthcare organizations to evaluate and manage provider networks. The company's platform supports adequacy analysis, compliance reporting for CMS, state, and employer requirements, identification of network gaps, access to a centralized provider dataset, competitive benchmarking, and provider outreach workflows such as collecting demographics, confirming network participation and appointment availability, and running regulatory surveys for CMS, state, and NCQA, enabling health plans and related healthcare organizations to maintain compliant networks and make network design decisions more efficiently.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 31
- Website
- j2health.com/
- Ownership
- Privately Held (backing)
J2 Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in J2 Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on J2 Health in its N-PORT filings yet. We sweep new filings monthly.